• Working with

    passion, integrity,
    & true innovation

  • Developing

    novel, first-in-class therapeutics

  • Targeting

    major unmet medical needs

  • Changing

    the approach to
    treating cancer

Imetelstat

First-in-class, first-in-clinic,
telomerase inhibitor

 

Telomerase

Learn about our innovative approach to developing a treatment for cancer

 

Geron Announces
Collaboration with Janssen

Click here for important information

 

Geron News

1.14.2016

Geron Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic Syndromes

Read More

11.30.2015

Geron Announces December Conference Presentation Webcasts

Read More

11.10.2015

Geron to Present at the Stifel Healthcare Conference

Read More

 

Events

12.09.2015

Geron at the Oppenheimer 26th Annual Healthcare Conference

Listen to Webcast

12.05.2015

Geron at the 57th American Society of Hematology (ASH) Annual Meeting

Listen to Webcast

Download slides

12.02.2015

Geron at the Piper Jaffray 27th Annual Healthcare Conference

Listen to Webcast